IPCA LABS Surges by 5%; BSE HEALTHCARE Index Up 0.2%
November 8, 2019 09:20 AM

IPCA LABS share price has zoomed 5% and is presently trading at Rs 1,103.

Meanwhile, the BSE HEALTHCARE Index is at 13,347 (up 0.2%).

Among the top Gainers in the BSE HEALTHCARE Index today is IPCA LABS (up 5.2%).

DR. REDDYS LAB and SANOFI INDIA (down 0.1%) are among the top losers today.

Over the last one year, IPCA LABS has moved up from Rs 688 to Rs 1,103, registering a gain of Rs 416 (up 54.6%).

On the other hand, the BSE HEALTHCARE has moved down from 14,536 to 13,347, loss of 1,189 points (down 8.2%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were DR. LAL PATHLABS LTD (up 68.1%), IPCA LABS (up 54.6%) and ABBOTT INDIA (up 54.5%).

What About the Benchmark Indices?

The BSE Sensex is at 40,631 (down 0.1%).

The top gainers among the BSE Sensex stocks today are POWER GRID (up 0.8%), SUN PHARMA (up 0.8%) and VEDANTA LTD (up 0.6%). Other gainers include INFOSYS (up 0.4%) and AXIS BANK (up 0.3%). The most traded stocks in the BSE Sensex are INFOSYS and VEDANTA LTD.

In the meantime, NSE Nifty is at 11,987 (down 0.2%). POWER GRID (up 0.5%) is among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 35,238 to 40,631, registering a gain of 5,393 points (up 15.3%).

IPCA LABS Financial Update...

IPCA LABS net profit down at Rs 1 billion for the quarter ended June 2019, compared to a loss of Rs 2 billion a year ago. Net Sales rose 6.7% to Rs 10.1 billion during the period as against Rs 9.5 billion in April-June 2018.

For the year ended March 2019, IPCA LABS reported 84.7% increase in net profit to Rs 4.4 billion compared to net profit of Rs 2.4 billion during FY18.

Revenue of the company grew 14.9% to Rs 38 billion during FY19.

The current Price to earnings ratio of IPCA LABS, based on rolling 12 month earnings, stands at 25.7x.